ReproNovo Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $65M

  • Investors
  • 4

ReproNovo General Information

Description

Operator of a health and reproductive medicine firm intended to develop and bring new treatments to patients. The company offers scientific expertise in designing and conducting clinical trials, development of orally administered therapeutic candidates for male and female infertility and uterine health, enabling healthcare providers and patients affected by fertility challenges to access emerging treatment options that aim to improve clinical outcomes.

Contact Information

Website
www.repronovo.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rue de Langallerie 11
  • 1003 Lausanne
  • Switzerland
Primary Industry
Other Healthcare Services
Other Industries
Drug Delivery
Vertical(s)
FemTech, Life Sciences
Corporate Office
  • Rue de Langallerie 11
  • 1003 Lausanne
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ReproNovo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 20-May-2025 $65M Completed Clinical Trials - Phase 2
1. Early Stage VC Completed Clinical Trials - Phase 2
To view ReproNovo’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

ReproNovo Patents

  • 29

    Total Documents Applications and Grants

  • Total Patents Families

  • 19

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

ReproNovo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12552754-B1 Leflutrozole compositions of matter and processes for preparation Active 11-Jun-2025
WO-2026018221-A1 Crystalline compositions for improving embryo implantation and methods of using the same Pending 18-Jul-2024
US-20250188043-A1 Leflutrozole compositions of matter and processes for preparation Inactive 07-Dec-2023
US-20220323410-A1 Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage Inactive 03-Sep-2019
US-20190247361-A1 Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage Inactive 21-Jul-2016 A61K31/40
To view ReproNovo’s complete patent history, request access »

ReproNovo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ReproNovo Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
ALSA Ventures Venture Capital Minority
Jeito Growth/Expansion Minority
M Ventures Corporate Venture Capital Minority
Ysios Capital Venture Capital Minority
To view ReproNovo’s complete investors history, request access »

Ready to get started?

Request a free trial

ReproNovo FAQs

  • When was ReproNovo founded?

    ReproNovo was founded in 2021.

  • Where is ReproNovo headquartered?

    ReproNovo is headquartered in Lausanne, Switzerland.

  • What is the size of ReproNovo?

    ReproNovo has 20 total employees.

  • What industry is ReproNovo in?

    ReproNovo’s primary industry is Other Healthcare Services.

  • Is ReproNovo a private or public company?

    ReproNovo is a Private company.

  • What is the current valuation of ReproNovo?

    The current valuation of ReproNovo is .

  • What is ReproNovo’s current revenue?

    The current revenue for ReproNovo is .

  • How much funding has ReproNovo raised over time?

    ReproNovo has raised $65M.

  • Who are ReproNovo’s investors?

    ALSA Ventures, Jeito, M Ventures, and Ysios Capital have invested in ReproNovo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process